Formation and resolution of brain edema associated with brain tumors. A comprehensive theoretical model and clinical analysis.
The purpose of this study is to quantify the relative contribution of the mechanisms in the absorption of edema fluid. The convection/diffusion and the comprehensive bulk flow model were applied for the finite element analysis of peritumoral brain edema. For clinical analysis, 90 meningiomas studied by MRI were selected. Serial CT scan and MRI were performed at 0, 2, 4, 6 hours after injection of Iopamidol or Gadpenteic acid respectively. Then the tracer distributions in the edematous brain was analyzed. The tracer movement in the brain is well represented by the convection/diffusion equation. The absence of the preferential fluid flow directing toward the ventricle indicates that a limited role of CSF sink action into the ventricle. From capillary surface area (240 cm2/g brain), capillary hydraulic conductivity (1.8 x 10(-8) ml/cmH2O/cm2/min) and the simulated average tissue pressure of 9.8 mmHg, maximum absorption rate into capillaries was estimated to be 0.003 ml/h/cm3 brain tissue. Considering the limited role of edema fluid clearance into the ventricle, the results indicate a possible role of subarachnoid CSF space for the clearance of edema fluid. The clearance of edema fluid into subarachnoid CSF space should be studied quantitatively. Finally, unification of the convection/diffusion and the comprehensive bulk flow model will provide a more quantitative analysis of edema formation and resolution by using MRI and tracer studies.
Nagashima
T
T
Department of Neurosurgery, Kobe University School of Medicine, Japan.
Tamaki
N
N
Takada
M
M
Tada
Y
Y
D001812:Blood-Brain Barrier / Q000502:physiology*; D001929:Brain Edema / Q000503:physiopathology*; D001932:Brain Neoplasms / Q000503:physiopathology*; D003287:Contrast Media; D018481:Convection; D004058:Diffusion; D004338:Drug Combinations; D019786:Gadolinium DTPA; D006801:Humans; D007479:Iopamidol; D008279:Magnetic Resonance Imaging; D008536:Meglumine; D008577:Meningeal Neoplasms / Q000503:physiopathology; D008579:Meningioma / Q000503:physiopathology; D008962:Models, Theoretical; D009942:Organometallic Compounds; D004369:Pentetic Acid / Q000031:analogs & derivatives; D014057:Tomography, X-Ray Computed; D014882:Water-Electrolyte Balance / Q000502:physiology
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D007479:Iopamidol; D019786:Gadolinium DTPA